newsfilter
← Latest News
GlobeNewswire·

Spyre Therapeutics to Participate in Upcoming Investor Conferences

  • Spyre Therapeutics (NASDAQ: SYRE) announced management participation in four upcoming investor conferences in November & December 2026.
  • The UBS Global Biopharma Conference is scheduled for Monday, November 16, 2026, at 1:20 pm GMT in London.
  • The Jefferies Global Healthcare Conference is scheduled for Tuesday, November 17, 2026, at 3:00 pm GMT in London.
  • The 9th Annual Evercore Healthcare Conference is scheduled for Tuesday, December 1, 2026, at 3:00 pm ET in Miami.
  • Citi's 2026 Global Healthcare Conference is scheduled for Wednesday, December 2, 2026, at 9:40 am ET in Miami.
  • Management will host one-on-one investor meetings during these events.
  • Live audio webcasts & replays will be available on the Spyre investor events website.
  • Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, IL-23, & IL-17A/F, along with combination programs.
Company
Spyre Therapeutics, Inc.
Keywords
Nasdaq:SYRE, Spyre Therapeutics, Inc., biotech, spyre